- Report
- April 2025
- 143 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- April 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 181 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- March 2025
- 180 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 179 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- May 2025
- 170 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- April 2025
- 307 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- September 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- April 2025
- 175 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- April 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- February 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 187 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 191 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 194 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 184 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 182 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 199 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP

Alpha emitters are a type of radioactive material used in nuclear medicine and radiopharmacology. They are used to diagnose and treat diseases such as cancer, and are typically administered to patients through intravenous injections. Alpha emitters are composed of short-lived, high-energy particles that can be used to target and destroy cancer cells. They are also used in research to study the effects of radiation on cells and tissues.
The alpha emitter market is a rapidly growing sector of the nuclear medicine and radiopharmacology industry. It is driven by the increasing demand for more effective treatments for cancer and other diseases. The market is expected to continue to grow as new technologies and treatments are developed.
Some of the major companies in the alpha emitter market include Nordion, Eckert & Ziegler, and IBA Molecular. These companies specialize in the production and distribution of alpha emitters for medical and research applications. Show Less Read more